SCHEMBL22038462

SCHEMBL22038462

CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)cc(-c4cccc(-c5ccccc5)c4)n3)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.47
▸ KMT2A Q03164 10/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ HPGD P15428 7/20 0.47
▸ MAPT P10636 6/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ LMNA P02545 2/20 0.47
▸ GLA P06280 1/20 0.43
▸ PDK2 Q15119 9/20 0.43
▸ NTSR1 P30989 1/20 0.42
▸ USP2 O75604 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25008569 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25008841 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17280881 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25008525 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24453367 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25008512 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25008842 1.00 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22308999 0.99 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22308615 0.99 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25008530 0.99 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 MEN1 3738/4885KMT2A 3571/4885ALDH1A1 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback